CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
Intramural Needle Ablation Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01791543
NCT01791543N/ACompleted

Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation

William Stevenson·interventional·Posted Feb 15, 2013·Updated Feb 1, 2023

In Brief

A clinical study evaluating Intramural Needle Ablation Catheter for Ventricular Tachycardia. Completed, enrolled 115 participants across 2 sites.

Detailed Summary

The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable because some people have ventricular arrhythmias that originate deep within the heart muscle where it is not abolished by ablation with standard catheters. The investigators seek to determine whether the INA catheter can potentially help people who have ventricular arrhythmias that have failed standard radiofrequency ablation. The investigators also want to determine if it is likely to be safe, without excessive side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 15, 2013
Enrollment StartSep 1, 2016
Primary CompletionMay 27, 2022
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 13.4 years ago

Interventions

Intramural Needle Ablation Catheterdevice